Company Information

Learn More About XBRL  

Address: 25 UPTON DRIVE  
City: WILMINGTON 
State: MA 
Zip Code: 01887 
Telephone: 978-657-7500 


Description of Business


Primary SIC Code: 2834
(As filed with the SEC)  

DUSA is a vertically integrated dermatology company that is developing and marketing Levulan® photodynamic therapy, or Levulan® PDT, and other products for common skin conditions. Our marketed products include Levulan® Kerastick® 20% Topical Solution with PDT, the BLU-U® brand light source, and ClindaReach®. We devote most of our resources to advancing the development and marketing of our Levulan® PDT technology platform. In addition to our marketed products, our drug, Levulan® brand of aminolevulinic acid HCl, or ALA, in combination with light, has been studied in a broad range of medical conditions. When Levulan® is used and followed with exposure to light to treat a medical condition, it is known as Levulan® PDT. The Kerastick® is our proprietary applicator that delivers Levulan®. The BLU-U® is our patented light device. The Levulan® Kerastick® 20% Topical Solution with PDT and the BLU-U® were launched in the United States, or U.S.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
09/20120.15NA45.27
06/20120.34NA15.35
03/20120.29NA21.59
12/20110.26NA16.85
09/20110.26NA14.23
06/20110.14NA44.43
03/20110.11NA47.27
12/20100.11NA22.27

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2011 Leverage 2011
Net Inc/Comm Equity0.05Total Liab/Total Assets0.26
Net Inc/Total Assets0.19Total Liab/Inv Cap0.31
Net Inc/Inv Cap0.23Total Liab/Comm Equity0.06
Pretax Inc/Net Sales0.15Interest Coverage RatioNA
Net Inc/Net Sales0.16Curr Debt/EquityNA
Cash Flow/Net Sales0.18LTD/EquityNA
SG&A/NetSales0.56Total Debt/EquityNA
Asset Utilization   Liquidity  
Net Receivables Turnover13.03Quick Ratio5.16
Inventory Turnover2.84Current Ratio5.60
Inventory Day Sales0.01Net Rec/Curr Assets0.10
Net Sales/Work Cap1.52Inv/Curr Assets0.08
Net Sales/PP&E28.29  

Income Statement (Millions)

  9/30/2012 6/30/2012 3/31/2012 12/31/2011
Total Revenues(Net Sales) 9.74 11.73 13.42 15.27
Cost of Goods Sold 1.51 1.78 2.07 2.41
Selling & Admin Exps 6.26 6.88 7.72 7.40
Operating Income 0.27 0.87 1.58 3.92
Interest Exp NA NA NA NA
Pretax Income -1.42 2.18 -0.34 3.41
Other Income -1.69 1.32 -1.92 -0.52
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -1.42 2.18 -0.34 3.31

Balance Sheet (Millions)

Assets 9/30/2012 6/30/2012 3/31/2012 12/31/2011
Cash & Short Term Investments 32.31 31.34 29.02 28.22
Receivables - Total 2.77 2.64 3.35 3.73
Inventories - Total 3.78 3.40 3.22 2.82
Total Current Assets 39.76 38.41 36.82 36.19
Net Property, Plant & Equipment 1.65 1.78 1.84 1.60
Total Assets 41.66 40.44 38.92 38.02
Liabilities        
Accounts Payable 5.53 5.24 5.25 5.61
Debt in Current Liabilities NA NA NA NA
Total Current Liabilities 5.69 5.49 5.57 6.47
Long-Term Debt NA NA NA NA
Total Liabilities 11.25 9.35 10.76 9.74
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock NA NA NA NA
Common Stock 151.85 151.77 151.76 151.99
Retained Earnings -133.91 -132.49 -134.67 -134.34
Treasury Stock NA NA NA NA
Total Stockholders' Equity 30.41 31.09 28.16 28.28
Total Liabilities and Stockholders' Equity 41.66 40.44 38.92 38.02

Cash Flow Summary (Millions)

Categories 9/30/2012 6/30/2012 3/31/2012 12/31/2011
Net Cash Provided by Operating Activities 0.91 2.61 1.22 4.00
Net Cash Provided by Investing Activities 1.19 -1.30 -0.18 -2.88
Net Cash Provided by Financing Activities 0.08 0.02 -0.23 0.00

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/200727.66-14.71-0.73
12/200829.55-6.25-0.26
12/200928.34-2.51-0.10
12/201036.422.700.11
12/201145.307.320.26
Growth Rates13.12----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional09/30/129816,16264.58




Report Date : 12/17/2012

Powered By Edgar Online Copyright 2012, EDGAR Online, Inc. All rights reserved. Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.